Bioadaptives Inc (PK)【BDPT】株式ニュース

Folks should read the quarterly report to understand this "company" makes no money and blatantly issues preferred stock to its "president" and two "directors" which are being converted into massive amounts of common shares.

In May 2024, the Company entered into an employment agreement as our chief executive officer. The Company agrees to pay a salary of $300,000 per annum. During the period ended June 30, 2025, the Company recorded payroll expense of $150,000 and the Company issued 18,955 shares of Series D Preferred Stock for payroll.

In May 2024, the Company entered into an employment agreement as our director with a one-year term. The Company agrees to pay a salary of $5,000 per month. During the period ended June 30, 2025, the Company recorded payroll expense of $30,000 and the Company issued 3,791 shares of Series D Preferred Stock for payroll.

In January 2025, the Company entered into an employment agreement as our director. The Company agrees to pay a salary of $5,000 per month. During the period ended June 30, 2025, the Company recorded payroll expenses of $25,000 for a director and the Company issued 2,842 shares of Series D Preferred Stock for payroll.

Next, follow the trail to see that these preferred shares are convertible at a rate of 100 to 1, and you can then see they are converting massive amounts (otherwise called dilution) for shares they paid nothing for.

Series D Preferred Stock

On July 2, 2024, the Company established its Series D Preferred Stock, par value $0.0001, by filing a Certificate of Designation with the Delaware Secretary of State. The Company’s board exercised “blank check” authority to establish classes of preferred stock without approval by shareholders under provision of its original Articles of Incorporation and has designated 20,000,000 shares of Series D Preferred Stock.

They may convert the Series D Preferred Stock to Common Stock at a rate of 100 shares of common stock for each share of Series D Preferred Stock. Each Series D Preferred Stock carries the voting rights equal to 100 shares of Common Stock.

During the period ended June 30, 2025, the Company issued 25,588 shares of Series D Preferred stock valued at $205,000 for compensation.

During the period ended June 30, 2025, one shareholder converted 8,333 shares of Series D Preferred stock to 833,300 shares of common stock.

During the period ended June 30, 2025, the Company issued 39,868 shares of Series D Preferred stock in cash for subscription of $300,000.

As of June 30, 2025, and December 31, 2024, 129,810 and 72,687 shares of Series D Preferred Stock are issued and outstanding, respectively.

Well, there is something called "sweat equity" for their efforts in the sense that actual profitable work would be done in order to obtain shares. However, this company had zero revenues in the past 3 months, and only $3,219 the first 3 months of the year.

The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses since inception and had an accumulated deficit of $9,518,356 as of June 30, 2025. The Company requires capital for its contemplated operational and marketing activities. The Company’s ability to raise additional capital through the future issuances of common stock is unknown. Obtaining additional financing, successful development of the Company’s contemplated plan of operations, and the transition, ultimately, to profitable operations are necessary for the Company to continue operations. The ability to successfully resolve these factors raises substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements of the Company do not include any adjustments that may result from the outcome of these aforementioned uncertainties.

In order to mitigate the risk related with this uncertainty, the Company plans to issue additional shares of common stock for cash and services during the next 12 months.

Dilution is a very bad thing when a company makes no money and is so far in debt.

During the period ended June 30, 2025, the Company issued 900,000 shares of common stock for stock payable.

During the period ended June 30, 2025, the Company issued 833,330 shares of common stock valued for conversion of Series D Preferred stock.

As of June 30, 2025, and December 31, 2024, there were 9,948,659 and 8,215,426 shares of the Company’s common stock issued and outstanding, respectively.

Here is the entire quarterly report for anyone to read:

https://www.otcmarkets.com/filing/html?id=18697068&guid=eDE-k60g_CVaJth